Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BioTek

BioTek Instruments, Inc., designs, manufactures, and distributes life science instrumentation. Its product line inclu... read more Featured Products: More products

Download Mobile App




Plasma Corin Levels Increased in Patients with Atrial Fibrillation

By LabMedica International staff writers
Posted on 12 Jul 2015
Corin is a transmembrane protease, which is expressed primarily in cardiomyocytes, where it converts the inactive proatrial natriuretic peptide (proANP) and probrain natriuretic peptide (proBNP) into active peptides.

Enzyme-linked immunosorbent assays (ELISA) have been used to measure both corin and N-terminal proANP (NT-proANP) concentrations in plasma samples of patients with different manifestations of atrial fibrillation (AF) and suitable controls. More...


Cardiologists at the First Affiliated Hospital of Dalian Medical University (China) recruited a total of 268 subjects, including 141 AF patients; 83 with paroxysmal AF, 58 with persistent AF and 127 controls. Paroxysmal AF (PAF) was defined as AF episodes lasting less than seven days and which terminated spontaneously. Persistent AF (PeAF) was defined as AF episodes lasting more than seven days and/or requiring termination with pharmacologic or direct current cardioversion.

An ELISA kit (R&D Systems; Minneapolis, MN, USA) was used to measure corin concentrations in the study. After the reaction the optical density (OD) in the wells was recorded by a spectrometer microplate reader (BioTek; Winooski, VT, USA) with the absorbance wavelength at 450 nm and correction at 570 nm within 20 minutes. An ELISA kit (Biomedica; Vienna, Austria) was used to measure NT-proANP concentrations and the OD was measured within 20 minutes by the spectrometer at 450 nm.

Plasma corin concentrations in patients with AF and PeAF were 1,209 ± 510 pg/mL and 1,377 ± 548 pg/mL, respectively, which were significantly higher than those in controls at 973 ± 528 pg/mL. However, the difference between the PAF patients and controls was not statistically significant at 1,092 ± 448 pg/mL versus 973 ± 528 pg/mL. The difference between the two patient groups was significant, 1,092 ± 448 pg/mL versus 1,377 ± 548 pg/mL. The concentrations in male controls were significantly higher than that in the female controls 1,120 ± 577 pg/mL versus 713 ± 281 pg/mL, and in male patients, the plasma corin concentrations were also higher than that in female patients, 1,365 ± 485 pg/mL versus 842 ± 358 pg/mL.

The authors concluded that high plasma corin concentrations in patients with AF suggests that corin may play an important role in the pathology of AF and that plasma corin, like proANP and ANP, may be a useful biomarker for AF, although no correlation was found between plasma corin and NT-proANP concentrations both in controls and in cases. The study was published on July 20, 2015, in the journal Clinica Chimica Acta.

Related Links:

First Affiliated Hospital of Dalian Medical University 
R&D Systems 
BioTeck



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.